Related Experiment Video
Updated: Apr 17, 2026
15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
8.7K
Increased serum hepcidin levels in brucellosis.
Clinical Laboratory
|February 5, 2015
Summary
Serum hepcidin levels are significantly elevated in Brucellosis patients, suggesting hepcidin may aid in diagnosing this infectious disease. However, it cannot distinguish between acute, subacute, or chronic Brucellosis.
Area of Science:
- Immunology
- Infectious Diseases
- Biochemistry
Background:
- Brucellosis immunity involves T lymphocytes and macrophage activation.
- Hepcidin, an antimicrobial peptide, regulates iron and is influenced by inflammatory cells.
- The role of hepcidin in Brucellosis requires further investigation.
Purpose of the Study:
- To investigate the association between serum hepcidin levels and Brucellosis.
- To determine if hepcidin levels can differentiate disease severity or duration.
Main Methods:
- Serum hepcidin levels were measured using a commercial ELISA kit.
- A cohort of 49 Brucellosis patients was compared to 52 healthy controls.
Main Results:
- Brucellosis patients exhibited significantly higher serum hepcidin levels than healthy controls (p < 0.001).
- No significant differences in hepcidin levels were observed across acute, subacute, and chronic Brucellosis cases.
- Hepcidin levels showed a positive correlation with C-reactive protein (CRP) in Brucellosis patients.
Conclusions:
- Elevated serum hepcidin may serve as a useful diagnostic marker for Brucellosis.
- Hepcidin levels are not suitable for differentiating between the acute, subacute, and chronic forms of Brucellosis.
